Catapult Ventures

Catapult Ventures, an independent asset management firm founded in 1999 and headquartered in Leicester, specializes in early-stage investments across various sectors, including technology, life sciences, healthcare, medical devices, luxury consumer brands, manufacturing, and software. The firm is staffed by a highly experienced team of venture capital investors with a broad background that encompasses all stages of company development, from start-ups and pre-revenue intellectual property developers to established firms generating significant revenue. This expertise is complemented by an administration team, where each member possesses over a decade of experience in the venture capital field. Through its dedicated approach, Catapult Ventures aims to support innovative companies in the UK, fostering growth and development in key industries.

Duncan Cameron

CFO and Director

Rob Carroll

Director

Christopher Spencer

Venture Partner

Nick Wright

CEO

98 past transactions

Strella Biotechnology

Series A in 2022
Strella biotech is a revenue-generating food supply chain company that provides data to optimize the produce supply chain via patented proprietary sensing technology. It specializes in the fields of supply chain management and big data. Strella was founded in 2018 by Jacob Jordan and Katherine Sizov and is based in Philadelphia, Pennsylvania, United States.

Urban Machine

Pre Seed Round in 2021
Urban Machine is a construction company that manufactures reclaims and co-creates locally sourced premium lumber products. The company's mission is to create a more sustainable future by reclaiming wood waste from construction and demolition and converting it into high-volume, locally sourced premium lumber products. It machine uses precision end-effectors, high-speed gantries, and vision systems for removing nails, screws, and staples.

Viscgo

Venture Round in 2021
Viscgo Limited design, develop and deliver innovative devices and technology to improve the management of dysphagia for people with swallowing disorders, their carers and clinicians.

Maxwellia

Venture Round in 2021
Maxwellia is a pioneering ‘prescription to over the counter’ medicines company which specialises in ‘switching’ - the conversion of prescription medicines into branded versions that can be bought without a prescription, over the counter (OTC).

Camect

Pre Seed Round in 2020
Camect is a very smart and private hub for your security cameras. Camect brings _continous_ local recording and 100% local object detection AI to your security cameras, plus a good UI and easy remote access. Manage hundreds of camera brands (including Nest, Arlo, and Wyze!) from one app, and get better alerts than any other consumer product, for orders of magnitude less than what a comparable feature set costs using common big brand consumer products.

Strella Biotechnology

Seed Round in 2020
Strella biotech is a revenue-generating food supply chain company that provides data to optimize the produce supply chain via patented proprietary sensing technology. It specializes in the fields of supply chain management and big data. Strella was founded in 2018 by Jacob Jordan and Katherine Sizov and is based in Philadelphia, Pennsylvania, United States.

Left Hand Robotics

Series A in 2019
Left Hand Robotics has developed the first commercial-class, self-driving snow clearing robot capable of removing snow from sidewalks and walkways. The SnowBot Pro is controlled and monitored remotely from an online management dashboard and uses GPS to follow a pre-programmed path. Its rotating brush clears a sidewalk from edge-to-edge in a single pass to meet even the highest standards.
Advanced Farm Technologies is a robotics company for the next frontier of farming. It offers strawberry harvesting services in the Oxnard, Santa Maria. and Watsonville areas. Its robots gently handle berries to avoid bruising and fruit damage. Advanced Farm Technologies was founded in Davis, California in 2017.

Rinicare

Venture Round in 2018
Rinicare is Lancaster-based SME that offers innovative technology solutions for healthcare applications.

Renephra

Seed Round in 2018
Renephra Ltd is a medical device company developing a groundbreaking Transdermal Fluid Removal (TFR) technology for minimally invasive fluid removal. We are targeting the significant problems of fluid overload and chronic oedema / lymphoedema in vascular, oncology and other disease areas. This is a substantial patient group with unmet clinical needs and is an estimated £1billion market worldwide. Having achieved proof of concept in humans, Renephra is raising £400k to conduct device development study and design feasability.

Acea Health

Seed Round in 2018
Acea Health is a digital healthcare company developing an application called Flynotes - a new digital consent platform. Flynotes analyses a number of factors, including the patient’s background, to deliver personalised risks and benefits. Flynotes aims to be the go-to solution for consent in healthcare. .

metaLinear

Seed Round in 2017
metaLinear focuses on the identification and validation of new drug targets for difficult to treat bacterial infections. metaLinear uses a proprietary proteome engineering platform technology to uncover, characterise and validate new targets for antibiotics. Using very large libraries of Randomised proteins (R-teins) expressed in target bacteria, metaLinear will screen for novel targets responsible for the desired phenotype. A key advantage of this approach is the ability to de-risk targets and hence provide multiple efficiency gains in the traditional target and drug discovery process.

MicroBioSensor

Venture Round in 2017
MicroBioSensor is a diagnostics company developing a range of products to detect early stage bacterial infections that are easy to use, point of care disposable devices. MicroBioSensor's initial focus is on the early detection of infection for patients on peritoneal dialysis and detection and antibiotic selection for suspected urinary tract infections.

Elucid mHealth

Series A in 2017
Elucid mHealth is a medication technology company creating adherence monitoring tools and virtual health platform aimed at improving clinical trial efficiencies. Elucid's novel product, Pill Connect, provides trial organizers with real-time adherence data and missed dose prevention, new dose data, protocol control, engagement measurements and automated dose reconciliation.

Proveca

Venture Round in 2017
Proveca Ltd is a pharmaceutical company specialising in identifying, researching and licensing off-patent medicines with unmet priority health care needs, with a focus on the paediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation (PUMA) these drugs will benefit from a period of 10 years' market protection (8 years of data and market protection plus 2 further years of market protection). In addition, where appropriate, Orphan Drug status (Orphan Drug) will be sought which affords a period of 10 years' market exclusivity to run concurrently. Value will be realised through commercialisation of the licensed medicine or an outright sale of the licence to a larger pharmaceutical company.

AMR Centre

Venture Round in 2017
Anti-Microbial Research Centre aims to accelerate the development of new antibiotics by providing development services to companies around the world in return for a commercial share from new products developed.

Apex Molecular

Venture Round in 2016
Apex Molecular is a synthetic chemistry company that is engaged in synthesis for the pharmaceutical, biotechnology, and applied chemical industries. They deliver laboratory-scale chemistry synthesis services for the life sciences and wider chemical sectors in a timely, dependable, and cost-effective manner.

SwabTech

Seed Round in 2016
SwabTech Ltd is a UK registered medical device company that has spun out of the UK NHS to develop, evaluate and commercialise an automatic swab washing device to support the use of Intra-Operative Cell Salvage within operating theatres. SwabTech are developing an automated Surgical Swab Washer to enhance blood recovery and reuse during high blood loss surgical procedures. SwabTech's patented Surgical Swab-Washer automates a process currently performed by hand, recovering blood from swabs used in the hospital operating theatre. This blood can then be processed and transfused back into the patient, an established procedure used in a wide range of operations associated with high blood loss, and is known to be a cost-effective means to improve clinical outcomes.

Blueberry Therapeutics

Venture Round in 2016
Blueberry Therapeutics Ltd. is a modern drug discovery and development company which puts people first whether patients, employees, investors or partners. We have created an open, imaginative and fun team environment with a very serious objective: to create new, safer and more effective medicines to treat human disease and make patients feel better. Blueberry focuses on the research and development of treatments for inflammatory and infectious diseases. We do this by employing state of the art preclinical research technologies to generate potent selective and safe molecules (peptides, antibodies, small molecules) for clinical development into new effective treatments to benefit patients. By focusing on well validated drug targets and ensuring our candidate molecules have a very low toxicity liability we believe we can mitigate or even avoid two of the major reasons for drug failures in the clinic.

Biorelate

Seed Round in 2016
Biorelate provides biomedical research services. It engages in the research of biomarkers for the diagnosis of prostate cancer; target validation; and new drug development services. Daniel Jamison founded Biorelate in 2014. It has its headquarters in Oldham in the United Kingdom.

Arlabion

Seed Round in 2016
Arlabion is an agri-tech company developing a novel seed treatment to protect crops against fungal infection. Arlabion's technology is a seed treatment that enhances the plant immune system response against pathogens, improves seed germination, facilitates root system development and reduces the risk of fungal disease. Arlabion's technology is targeted at a large and fast-growing market opportunity for less toxic and damaging agents to address the fungal infection in important food crops. Arlabion makes use of well-proven organic chemistry more traditionally applied to human and animal healthcare into agriculture.

Kanichi Research Services

Venture Round in 2016
Kanichi Research Services are developing novel non-invasive diagnostic systems that measure analytes in exhaled breath for the rapid detection and diagnosis of a range of diseases. The lead product is a low-cost, disposable, point of care test for the detection and diagnosis of Helicobacter Pylori (H. pylori), a bacterial infection in the gut which can lead to stomach ulcers and stomach cancer.

Monica Healthcare

Seed Round in 2015
Based in the United Kingdom, Monica Healthcare is developing a series of innovative wearable devices that will use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. The patented technology is based on the acquisition of electro-physiological signals that can be passively detected by electrodes positioned on the maternal abdomen.

Michelson Diagnostics

Series A in 2014
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

4energy

Corporate Round in 2013
Located in Nottingham, 4energy produces cooling solutions that deliver up to 50% energy savings over traditional cooling products across the data centre and telecoms industries.

activ8 Intelligence

Venture Round in 2013
Activ8 Intelligence Limited provides HR software. The company offers HR reporting and analytics solutions; predictive workforce planning tools that enable organizations to make resourcing, recruitment, and talent management decisions; and predictive screening and selection solutions. It also provides metrics and measurement design, data analysis and interpretation, and human capital consultancy services. activ8 Intelligence was formerly known as active8 Human Resources Limited and changed its name in March 2007. The company was incorporated in 2005 and is based in Farnsfield, the United Kingdom.

Haemostatix

Venture Round in 2012
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

Biofortuna

Venture Round in 2012
Biofortuna provides molecular diagnostics services. It manufactures HLA and ABO genotyping product families for the transplantation and haematology markets. The company is also developing antibody screening, genotyping and phenotyping products, software for genotyping applications, transplant monitoring, and platforms for clinical laboratories, research centers and point-of-care customers. In addition, Biofortuna Ltd. provides genotyping and custom assay development services. The company was incorporated in 2008 and is based in Liverpool, the United Kingdom.

Echo Ltd.

Venture Round in 2012
echo provides an extensive and bespoke range of IT and logistical support services through an outsourced partnership model. The service focused, flexible solutions enhance, expand and complement an existing service portfolio, improving cost efficiency while maintaining the highest quality service levels.

Comply Serve

Venture Round in 2012
Comply Serve is a software company offering compliance and validation solutions to highly regulated industries. The company evolved out of the world's leading provider of requirements management solutions, Telelogic AB, where the founding team discovered a significant and largely untapped market opportunity for project supply chain compliance solutions. After 3 years spent researching the compliance market, it started trading in January 2006.

Michelson Diagnostics

Venture Round in 2012
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

BioFilm

Venture Round in 2012
BioFilm has established a world-class manufacturing and development facility and concluded supply agreements for several significant customers. The company is a producer of dissolvable thin film for use in the nutraceutical, cosmetics, wound care, pharmaceuticals and medical professions in Europe.

Stage Coach

Acquisition in 2012
Stagecoach is a network of performing arts schools that teaches children and young people to sing, dance and act in a fun, educational, and stimulating environment

Biofortuna

Venture Round in 2012
Biofortuna provides molecular diagnostics services. It manufactures HLA and ABO genotyping product families for the transplantation and haematology markets. The company is also developing antibody screening, genotyping and phenotyping products, software for genotyping applications, transplant monitoring, and platforms for clinical laboratories, research centers and point-of-care customers. In addition, Biofortuna Ltd. provides genotyping and custom assay development services. The company was incorporated in 2008 and is based in Liverpool, the United Kingdom.

Oracle Care and Education

Venture Round in 2011
Oracle Care is a provider of specialist education, therapeutic and residential care services designed to support young people aged between ten and eighteen who have a range of complex needs.

Hangar Seven

Venture Round in 2011
Hangar Seven is a creative production business that works with both clients and agencies to provide an end-to-end solution for superb, yet cost effective marketing services delivery from our 50,000 sq ft facilities in London, South Manchester & Portugal. From one single point of contact we create, manage and distribute marketing and advertising assets to over 87 countries worldwide. Striking and creative photography can be produced in any one of our large studios, beautiful flyers and catalogues are crafted and put together by our publications team and above the line advertising is produced, reversioned and disseminated perfectly to press, outdoor, online and TV channels all around the globe.

5Degrees

Seed Round in 2011
5Degrees develops mobile and web-based CRM tools for startups and small businesses to grow sales. Its product portfolio includes 5Degrees CRM, an iPhone CRM App; Networker, a business card scanning app; and 5Degrees CRM Web. 5Degrees’s products enable users to import contacts from address books or Google contacts; put people into circles to easily manage overlapping networks; sync contacts with iPhones; use quick notes systems to jot notes; use templated emails and schedule them to be sent in the future; schedule to-do’s or tasks to keep in touch with contacts; receive alerts about the tasks for the day; view to-do lists; and call and email contacts. Its special features include LinkedIn integration, Box.com integration, offline facilities, multi-device synchronization, iPhone interfaces, and more. 5Degrees was founded in June 2011 and is based in Chicago, Illinois.

Haemostatix

Series C in 2011
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

KickSport

Venture Round in 2011
Kicksport.com is a martial arts equipment specialist, providing equipment and uniforms for Judo, Karate, and Taekwondo. KickSport's ethos is to provide quality clothing and exceptional customer service to all. KickSport's values include energy, dedication, leadership, evolution, aspiration, community, fashion, and quality.

Intelligent Orthopaedics

Venture Round in 2011
Intelligent Orthopaedics designs, develops, and manufactures orthopedic trauma devices for treating and reducing fractures of the tibia. It offers STORM (The Staffordshire Orthopaedic Reduction Machine), a re-usable surgical device for the reduction of fractures throughout the tibia. The company also provides IOS, a single use fixator to treat unstable tibial shaft fractures. Intelligent Orthopaedics was incorporated in 2002 and is based in Newcastle-under-Lyme, United Kingdom. As of September 05, 2016, Intelligent Orthopaedics is in liquidation.

Haemostatix

Venture Round in 2010
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

Oxford Cryosystems

Acquisition in 2010
Oxford Cryosystems is privately held with 20 employees, and is a market-leading UK manufacturer of highly specialised scientific instruments and software. The company originated in a laboratory of Oxford University in the 1980s and has since grown into a high-tech commercial organisation. To date, Oxford Cryosystems products have contributed to advances in fields as diverse as pharmaceuticals, telecoms, green energy and astronomy. Customers include universities, high-tech manufacturers, drugs companies and research institutes throughout the world. More than 80% of production is currently exported, whilst at least 90% of the company’s suppliers are British-based. For more information, visit www.oxcryo.com.

nanoTherics

Venture Round in 2010
nanoTherics gene transfection studies have shown a significant performance enhancement over the best non-viral techniques currently on the market, demonstrating high levels of transfection whilst, importantly, maintaining the viability of the transfected cells. These two key attributes afford a significant competitive advantage over currently available systems. nanoTherics’s mission is to position its novel gene transfection technology as the new “gold standard” for transfection, underpinning the research and development of current and future gene therapy programmes.

Yospace Technologies

Venture Round in 2010
Yospace is a mobile applications innovator and platform provider allowing digital publishers, mobile applications developers, and mobile operators to rapidly and affordably deliver mobile video services. The technology enables intelligent streaming thus promoting ad insertion and ad replacement enabling the content owner to monetise their content effectively. It specializes in workflow and delivery for multi-screen non-linear, linear, and live streaming. The company offers yospaceCDS, a mobile and Web-based video delivers platform that provides a basis for publishers, broadcasters, video ad networks, and applications developers to enable live and on-demand video services with in-stream ad insertion. It also offers a range of broadcast head-end solutions to enable the stream conditioning and ad avail detection required for dynamic ad insertion in live streaming, including automation system integration, placement opportunity information service, scheduling integration, and blackout management. The company was founded in 1999 and is based in Staines-upon-Thames, United Kingdom. Yospace Technologies Ltd. is a former subsidiary of Bauer Consumer Media Ltd.

Silver Lining Solutions

Venture Round in 2010
Silver Lining Solutions enables organisations to pinpoint and replicate the employee skills, knowledge and attributes that drive the best business outcomes - quickly, cost-effectively and at scale. Companies around the world use our unique software solutions to transform the customer experience and achieve step change improvements in sales performance and operational efficiencies. Our teams have deep industry knowledge and extensive exposure to customer management, contact centre and back office environments. This first-hand exposure helps us see things from your point of view - we understand the challenges you face and know how to overcome them to unlock significant business benefits.
Renewable Technical Services Limited is a provider of installation, repair and maintenance services to the wind energy sector. The company supports major OEMs under preferred supplier / framework agreements, as well as working for the major power companies and wind-farm operators under long-term arrangements. With over 20 years of experience in installation and maintenance of met masts and wind turbines, the RTS team is available 24 hours a day, 7 days a week to support the wind energy industry. Having provided services to over 268 wind farms in the UK, it has worked on over 5,000 wind turbines. Our reach extends further still, with RTS engineers having worked on contracts in New Zealand, the Dominican Republic, Libya, South Africa and throughout Europe.

Biofortuna

Venture Round in 2010
Biofortuna provides molecular diagnostics services. It manufactures HLA and ABO genotyping product families for the transplantation and haematology markets. The company is also developing antibody screening, genotyping and phenotyping products, software for genotyping applications, transplant monitoring, and platforms for clinical laboratories, research centers and point-of-care customers. In addition, Biofortuna Ltd. provides genotyping and custom assay development services. The company was incorporated in 2008 and is based in Liverpool, the United Kingdom.

Oxford BioTherapeutics

Venture Round in 2010
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

Zinwave

Funding Round in 2010
Zinwave UK is a global provider of wideband active distributed antenna systems for in-building wireless coverage.

Intellitect Water Holdings

Venture Round in 2010
Intellitect has developed a water quality monitoring system that allows your distribution network to talk to you. It gives you all the information you need to ensure a high-quality product reaches the customer. Water companies produce high-quality water at the treatment plants under well-controlled conditions, however, once the water is pumped into the distribution network they lose the ability to monitor its quality. Our Insight system alerts you if there is a problem and tells you where and when, straight to your computer or mobile device, allowing you to act quickly.

Intamac Systems

Venture Round in 2009
Intamac Systems Limited provides Internet accessed monitoring and control services to the home and business markets. The company offers an Internet platform and portal, which connects various products, appliances, and devices, networking them together to deliver monitoring and control services. Its open platform permits two-way monitoring and control solutions through mobile phones or over the Internet with a messaging service that provides alerts, such as power failure, flood, fire, burglary, and camera activation. The company's monitoring and control services include alarm monitoring, elderly care, flood detection, fire detection, camera monitoring, environmental monitoring, and guarding cover. The company was founded as Elinx Limited in April 2000 and later changed its name to Intamac Systems Limited in September 2000. The company is based in Northampton, United Kingdom.

Probe Scientific

Series A in 2009
Probe Scientific is developing innovative products to solve clinical problems and improve healthcare. The company has a substantial product pipeline based on its proprietary technologies and is seeking to commercialise this range to simultaneously benefit clinicians and the community in general. Probe Scientific Ltd is a private company, founded in 1998 and is based in the West Midlands, UK. Probe Scientific has grown steadily since its origins as a research organisation and has recently recruited experienced senior executives with a commercial focus.

Accutronics

Venture Round in 2009
Accutronics is a independent battery and charger design, development and manufacturing company for high-performance portable and handheld electronic devices, specialising in the development and manufacture of 'smart batteries'. Medical Device, Defence & Security, Industrial Electronics, Portable Electronic Device and Robotics OEMs worldwide rely on Accutronics' expertise to integrate the latest cell technology, electronic fuel gauging, active safety systems and innovative enclosure designs to power the next generation of rechargeable battery powered devices. Our class leading, high energy density smart battery technology enables OEMs to make portable devices smaller, lighter and safer.

Systems Integration (Trading) Limited

Private Equity Round in 2009
Systems Integration (Trading) Limited supplies software and hardware solutions for the food processing industry. It offers Sistem 7 SHOP FLOOR DATA CAPTURE, which provides solutions for removing manual capture and transfer of information; Sistem 7 SALES ORDER PROCESSING, a system that offers an Explorer interface; and Sistem 7 BONING HALL, which is a program that allows quarters to be issued to the boning hall stock at the beginning of the boning process.

Systems Integration

Venture Round in 2009
Systems Integration is one of the worlds leading suppliers of hardware and software solutions for the meat processing industry. With a wealth of knowledge drawn from their own experiences in the field, they have the ability to supply your organisation with state of the art technology coupled with bespoke software thus enabling your operation to run smoothly and efficiently.

Monica Healthcare

Venture Round in 2009
Based in the United Kingdom, Monica Healthcare is developing a series of innovative wearable devices that will use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. The patented technology is based on the acquisition of electro-physiological signals that can be passively detected by electrodes positioned on the maternal abdomen.

Warwick Effect Polymers

Venture Round in 2009
Warwick Effect Polymers Limited manufactures and markets complex polymers using living controlled radical polymerization.

Comply Serve

Venture Round in 2009
Comply Serve is a software company offering compliance and validation solutions to highly regulated industries. The company evolved out of the world's leading provider of requirements management solutions, Telelogic AB, where the founding team discovered a significant and largely untapped market opportunity for project supply chain compliance solutions. After 3 years spent researching the compliance market, it started trading in January 2006.

Comply

Venture Round in 2009
Comply provides specialized, off-the-shelf scientific and process data management software products, and offers Professional Consulting Services to support and enhance Life Science companies in successfully meeting unique industry demands.

Oxford BioTherapeutics

Venture Round in 2009
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

Key Technologies

Seed Round in 2008
Key Technologies, through its subsidiaries, provides engineering solutions in the areas of Defense and Homeland Security. The company manufactures and supplies specialist ammunition, 12 gauge, EOD, and public order solutions through a distribution network worldwide. It also engages in design, electronic manufacturing, and through-life system engineering services. Key Technologies was founded in 2003 and is based in Cradley Heath, United Kingdom.

4energy Ltd.

Venture Round in 2008
4energy Ltd. develops energy cooling systems and platforms for telecommunications and equipment rooms.

4energy

Venture Round in 2008
Located in Nottingham, 4energy produces cooling solutions that deliver up to 50% energy savings over traditional cooling products across the data centre and telecoms industries.

Sight and Sound Limited

Acquisition in 2008
Sight and Sound is a UK-based provider of hardware and software to the blind, visually impaired and those with learning and reading difficulties.

Oxford BioTherapeutics

Venture Round in 2008
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

Silver Lining Solutions

Venture Round in 2008
Silver Lining Solutions enables organisations to pinpoint and replicate the employee skills, knowledge and attributes that drive the best business outcomes - quickly, cost-effectively and at scale. Companies around the world use our unique software solutions to transform the customer experience and achieve step change improvements in sales performance and operational efficiencies. Our teams have deep industry knowledge and extensive exposure to customer management, contact centre and back office environments. This first-hand exposure helps us see things from your point of view - we understand the challenges you face and know how to overcome them to unlock significant business benefits.

Haemostatix

Venture Round in 2008
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

BWB Consulting

Private Equity Round in 2008
BWB Consulting is an integrated engineering and environmental consultancy that delivers multi-disciplinary engineering solutions to the property, development and construction industry. BWB Consulting provides over 70 services, in 15 sectors to an international client base. It offers building and built environment services ranging from designing new buildings to adapting, refurbishing, and maintaining existing building stocks; and from initial feasibility study to planning, detailed design, construction, routine maintenance, decommissioning, and demolition services for public and private sector development projects. Its environment services include advisory, investigative, design, and validation services relating to various aspects of the ground and water environment. The company also provides transport and infrastructure services, which include planning and designing multi-modal transport infrastructure. It serves industrial and manufacturing, education, retail, leisure and hospitality, residential, distribution, energy and carbon, retail, urban regeneration, commercial, health, public, culture and heritage, road and rail, finance and investment, and water environment sectors. The company was founded in 1990 and is based in Nottingham, United Kingdom. As of July 12, 2017, BWB Consulting Limited operates as a subsidiary of Construcciones y Auxiliar de Ferrocarriles, S.A.

activ8 Intelligence

Venture Round in 2008
Activ8 Intelligence Limited provides HR software. The company offers HR reporting and analytics solutions; predictive workforce planning tools that enable organizations to make resourcing, recruitment, and talent management decisions; and predictive screening and selection solutions. It also provides metrics and measurement design, data analysis and interpretation, and human capital consultancy services. activ8 Intelligence was formerly known as active8 Human Resources Limited and changed its name in March 2007. The company was incorporated in 2005 and is based in Farnsfield, the United Kingdom.

R2C Online

Seed Round in 2008
R2C Online provides a community data network for the management and communication of commercial vehicle inspection and maintenance records.

L3 Technology

Venture Round in 2008
L3 Technology develops a point of care testing system for reading blood analytes from various samples. It offers a lipid profile testing system for measuring a multi-fraction lipid profile from a finger stick sample of blood, serum, or plasma. The company was incorporated in 2001 and is based in Coventry, United Kingdom. As of December 16, 2016, L3 Technology was acquired by Jupiter Diagnostics.

Eden Luxury Group

Venture Round in 2008
Eden Luxury is a Chester-based travel brand that provides high end holidays through its Seasons in Style and Eden Collection.

Abzena

Venture Round in 2008
Abzena is a biologics research partner. They provide biologic and ADC products from concept to clinic. They develop biologics and bioconjugates, and provides the solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry.

CellAura

Venture Round in 2008
CellAura Technologies is the home of innovative screening products for the drug discovery industry. CellAura is a spin-out company from the University of Nottingham. Combining world-renowned expertise in the fields of synthetic chemistry and molecular pharmacology, CellAura produces high-quality fluorescent G-protein coupled receptor ligands for use in molecular pharmacology and imaging at the single cell level.

Atlantic Link Limited

Venture Round in 2008
Atlantic Link Limited develops rapid e-learning training products which enable users to design and deliver professional on-line training to thousands of employees which would, in the past, have taken months to create at great cost. It offers Content Point, a remote authoring system that enables the development of e-learning courses; Capture Point, a capture tool for the automatic creation of online software training courses; and Knowledge point, a collaboration server and learning management system that provides course launch and tracking, results storage, student import, and user and author grouping functions. The company also specializes in project management, instructional design, branding and design, technical, and account management areas, as well as provides eLearning support and hosted solutions. It serves corporate clients, as well as government and higher education markets through a network of resellers globally. Atlantic Link Limited was founded in 2002 and is based in Nottingham, United Kingdom with an additional office in Atlanta, Georgia.

SolarTech Ltd.

Venture Round in 2008
SolarTech Ltd., is the designer and installers of renewable energy systems.

Synchro

Venture Round in 2007
Synchro, Ltd. provides project management solutions. It provides Synchro 4D, a project management and 4D visualisation solution that incorporates the ability to define and represent the physical properties of resources, and communicate these in 3D and 4D. The company also provides Synchro Server that acts as a bridge between project participants and enables to broadcast the changes made on one client to all other connected participants. Its products are used in various construction and refurbishment projects in commercial, civil, and residential segments. The company was founded in 2001 and is based in Coventry, the United Kingdom.

Monica Healthcare

Venture Round in 2007
Based in the United Kingdom, Monica Healthcare is developing a series of innovative wearable devices that will use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. The patented technology is based on the acquisition of electro-physiological signals that can be passively detected by electrodes positioned on the maternal abdomen.

Blackstar Amplification

Private Equity Round in 2007
Blackstar Amplification Limited, a UK-based designer and manufacturer of innovative guitar amplifiers and effects pedals. Blackstar Amplification is based in Northampton, England. The company's four founding directors are all musicians and have over 50 years combined experience in guitar amplification design and production.

R5 Pharmaceuticals Ltd.

Seed Round in 2007
R5 Pharmaceuticals Ltd. engages in the contract development and manufacture of clinical trials materials.

Critical Pharmaceuticals

Series B in 2007
Critical Pharmaceuticals is a biotechnology company with proprietary drug delivery technologies for the sustained release and nasal delivery of proteins and peptides and labile or insoluble small molecules. Critical Pharmaceuticals was founded by Professor Steve Howdle in 2002 based on his research into supercritical fluids. When gases reach a certain temperature and pressure (the critical point) they become "supercritical" and take on both gas and liquid like properties. He noticed that supercritical carbon dioxide (scCO2) was able to penetrate certain polymers, and in a moment of inspiration realised that this could be used to mix thermally labile or solvent sensitive substances into the polymers.

Oxford BioTherapeutics

Venture Round in 2007
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

Michelson Diagnostics

Seed Round in 2007
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

Zysis Limited

Venture Round in 2007
Zysis Limited is a pharmaceutical company that optimizes therapies for disorders of the central nervous system to improve sufferers’ lives. Zysis is currently developing two new treatments. One is a once-weekly, oral tablet for the treatment of Psychotic conditions or an adjunctive treatment for Major Depressive Disorder (Aripiprazole Oral Once Weekly). The other is a once-daily, effective formulation for the treatment of speciality Anxiety disorders such as Panic Disorders and Post-Traumatic Stress Disorder (Nocturel).

Anaxsys Technology

Venture Round in 2007
Anaxsys Technology is a medical device company that develops and markets respiratory devices. The company offers respiR8, a continuous respiratory rate counter that provides an early indication of patient deterioration; and asthma monitoring systems. Its products target at patient monitoring, screening, and diagnostics in the areas of asthma, vital signs, sleep apnea, and lung cancer. The company was formerly known as Asthma Alert Limited and changed its name to Anaxsys Technology Ltd. in August 2006. Anaxsys Technology was founded in 2002 and is based in Send, United Kingdom.

Whelan Refining

Venture Round in 2006
Whelan Refining Ltd recycles waste oil to produce base oil - the base for all industrial and automotive lubricants. It re-refines 50,000 tonnes per annum of used oils to produce a high-quality group I base oil for sale to the lubricant manufacturing industry. Whelan Refining was founded in 2005 and is based in Stoke-on-Trent, UK.

David Holmes BMW

Private Equity Round in 2006
Sytner Group Limited operates as a new and used car dealership company.

Critical Pharmaceuticals

Venture Round in 2005
Critical Pharmaceuticals is a biotechnology company with proprietary drug delivery technologies for the sustained release and nasal delivery of proteins and peptides and labile or insoluble small molecules. Critical Pharmaceuticals was founded by Professor Steve Howdle in 2002 based on his research into supercritical fluids. When gases reach a certain temperature and pressure (the critical point) they become "supercritical" and take on both gas and liquid like properties. He noticed that supercritical carbon dioxide (scCO2) was able to penetrate certain polymers, and in a moment of inspiration realised that this could be used to mix thermally labile or solvent sensitive substances into the polymers.

Ergomed

Venture Round in 2005
Ergomed plc is a profitable UK-based company, dedicated to the provision of specialized services to the pharmaceutical industry and the development of new drugs. Ergomed plc has two complementary businesses: - The Services Business – a well-established, clinical research business providing services to the pharmaceutical and biotechnology industry; and - The Co-Development Business – a growing portfolio of partnerships with pharmaceutical and biotech companies, providing its drug development services in exchange for a carried interest in any revenues attributable to the drug asset, including outlicensing milestones as well as sales of the product.

Monica Healthcare

Seed Round in 2005
Based in the United Kingdom, Monica Healthcare is developing a series of innovative wearable devices that will use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. The patented technology is based on the acquisition of electro-physiological signals that can be passively detected by electrodes positioned on the maternal abdomen.

Demon Tweeks

Acquisition in 2004
Demon Tweeks is a retailer of high performance equipment and accessories for motorsport competitors, car tuners, and motorcycle enthusiasts.

Cyclops

Venture Round in 2004
Cyclops offers safety camera databases, update services, and related software. Cyclops' coverage now extends across 41 countries and includes over 85,000 sites. Users of Cyclops devices, software and databases know they can rely on Cyclops' solutions to help them arrive safely at their destination, and with their driving record intact. Cyclops delivers tailored solutions for clients operating on all types of software and hardware platforms including personal navigation, connected mobile devices, and OEM satnav solutions. Today, Cyclops' databases and software can be found in leading satellite navigation, mobile, and automotive brands, Cyclops now provides a Live Alert Service for connected PND and mobile navigation users.

Cyclops Electronics

Venture Round in 2004
Cyclops Electronics Ltd. distributes electronic components to original equipment manufacturers worldwide.
Food and Drug Analytical Services Ltd. is an independent providers of pharmaceutical quality control testing. FDAS delivers a full contract testing service - incorporating chemistry, microbiology, stability and development capabilities - to some of the UK's largest pharmaceutical companies.

De-Pack Ltd.

Venture Round in 2004
De-Pack Ltd. provides de-packaging, recycling, and recovery of aerosols.

Turbine Efficiency

Venture Round in 2003
Turbine Efficiency is a provider of after-market services for industrial gas turbines, specialising in sub-10MW machines. It also offers light industrial gas turbine equipment solutions for the oil, gas, and power & industrial markets. Turbine Efficiency specialising in the SGT-100 (Typhoon), SGT-200 (Tornado), SGT-300 (Tempest), TA and TB gas turbines. Turbine Efficiency has received the Lincolnshire Energy Awards - Exporter of the Year 2014. It was founded in 2000 and is headquartered in Lincoln, UK.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.